Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum

Credit: IndiaTimes- Published on April 20, 2021
Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Tuesday said it has scaled up its manufacturing capacities of Covaxin to 700 million doses per annum making it one of the largest production capacities for Inactivated viral vaccines globally. The company said the scale-up has been carried out across...

You are here


💡 newsR Knowledge: Other News Mentions

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Amid the reports of coronavirus vaccine shortage from various states, the Central government and Hyderabad-based Bharat Biotech are willing to invite other..
Credit: IndiaTimes - Published 2 days ago

Suchitra Ella's tweet evoked mixed response from netizens with some questioning the effectiveness while others asked why the staff was not vaccinated.
Credit: DNA - Published 2 days ago

The Indian drugs regulator, the Drugs Controller General of India (DCGI) has granted its approval to indigenously developed Covid-19 vaccine Covaxin’s..
Credit: IndiaTimes - Published 2 days ago


BBV152

Vaccine against COVID-19
In a series of tweets, Chidambaram said the suggestion for compulsory licences be issued to other manufacturers had been offered by the Congress four weeks..
Credit: IndiaTimes - Published 19 minutes ago

The government on Thursday dismissed as "completely baseless and factually incorrect" reports in a section of media followed by some tweets alleging delay in..
Credit: IndiaTimes - Published 2 days ago


COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
Mamata Banerjee's brother Ashim Banerjee was undergoing treatment for COVID-19 at Medica Hospital in Kolkata.
Credit: DNA - Published 1 hour ago

West Bengal CS, on Saturday, announced some additional restrictions given the surge in COVID-19 cases in the state.
Credit: DNA - Published 2 hours ago

India on Saturday reported the lowest daily cases in 18 days even as the figure significantly remains above the 3-lakh mark. In terms of Covid-19 deaths, the..
Credit: IndiaTimes - Published 3 hours ago

Prime Minister Narendra Modi in the meeting to be held today will also review preparations against the upcoming Cyclone Tauktae.
Credit: DNA - Published 3 hours ago


Hyderabad

Capital of Telangana, India
Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
Credit: IndiaTimes - Published 1 day ago

Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
Credit: IndiaTimes - Published 1 day ago


Bangalore

Capital of Karnataka, India
The Centre’s advisory to states to extend the interval between the first and second doses of Covishield vaccine to 12-16 weeks from the earlier 6-8 weeks has..
Credit: IndiaTimes - Published 10 hours ago

The researchers who predicted the figure took into account the ongoing vaccination drive in the state and lockdown-like restrictions into account.
Credit: DNA - Published 5 days ago

Karnataka government has decided to impose a complete lockdown from 6 am on May 10 till 6 am on May 24 due to the increasing number of COVID-19 cases.
Credit: DNA - Published 1 week ago


Related videos from verified sources

Covaxin unavailable, Delhi suspends vaccination at 100 centres | Oneindia News 02:36
Credit: Oneindia - Published 2 days ago 


Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News 03:17
Credit: Oneindia - Published 3 days ago 


Delivered over 200 million vaccine doses to European people: EU Commission President 01:01
Credit: ANI - Published 1 week ago 


Related news from verified sources

Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Tuesday said it has scaled up its manufacturing capacities of Covaxin to 700 million...
on April 20, 2021 • IndiaTimes

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its Covid-19 vaccine, Covaxin, to 700...
on April 20, 2021 • IndiaTimes

Sputnik V is the 3rd vaccine India has given approval to after the University of Oxford, AstraZeneca vaccine COVISHIELD and Indian Vaccine manufactured by Bharat...
2 weeks ago • Zee News

You might like